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The OprM lipoprotein of Pseudomonas aeruginosa is a
member of the MexAB-OprM xenobiotic-antibiotic
transporter subunits that is assumed to serve as the
drug discharge duct across the outer membrane. The
channel structure must differ from that of the porin-
type open pore because the protein facilitates the exit of
antibiotics but not the entry. For better understanding
of the structure-function linkage of this important
pump subunit, we studied the x-ray crystallographic
structure of OprM at the 2.56-Å resolution. The overall
structure exhibited trimeric assembly of the OprMmon-
omer that consisted mainly of two domains: the mem-
brane-anchoring -barrel and the cavity-forming -bar-
rel. OprM anchors the outer membrane by two modes of
membrane insertions. One is via the covalently attached
NH2-terminal fatty acids and the other is the -barrel
structure consensus on the outer membrane-spanning
proteins. The -barrel had a pore opening with a diam-
eter of about 6–8 Å, which is not large enough to accom-
modate the exit of any antibiotics. The periplasmic
-barrel was about 100 Å long formedmainly by a bundle
of -helices that formed a solvent-filled cavity of about
25,000 Å3. The proximal end of the cavity was tightly
sealed, thereby not permitting the entry of any mole-
cule. The result of this structure was that the resting
state of OprM had a small outer membrane pore and a
tightly closed periplasmic end, which sounds plausible
because the protein should not allow free access of an-
tibiotics. However, these observations raised another
unsolved problem about the mechanism of opening of
the OprM cavity ends. The crystal structure offers pos-
sible mechanisms of pore opening and pump assembly.
Infection of Pseudomonas aeruginosa is problematic in hos-
pitals because the organism often infects immunocompromised
patients and threatens their life. The underlying problem in
the infection of this organism is that the bacterium shows both
natural and mutational resistance to structurally and function-
ally dissimilar xenobiotics-antibiotics (1–4). This low specific
antibiotic resistance is mainly attributable to the interplay of
the multidrug exporter(s) and tight outer membrane barrier
(5, 6).
P. aeruginosa encodes several resistance nodulation cell di-
vision-type transporters, and among them, the MexAB-OprM
multidrug transporter plays a central role in intrinsic multi-
drug resistance of this organism (2, 7, 8). Upon mutation of the
regulatory gene, mexR, the cell produces large amounts of
MexAB-OprM rendering the bacterium severalfold more resist-
ant to the same spectrum of antibiotics than the wild-type
strain (4, 7, 8). The MexAB-OprM transporter consists of three
subunit proteins, MexA, MexB, and OprM, located in the inner,
inner, and the outer membrane, respectively (2, 9). MexB se-
lects substrates and exports them by the expenditure of the
energy of proton gradient across the cytoplasmic membrane
(10). MexA, which is the inner membrane-anchored lipoprotein
exposing the entire protein moiety to the periplasmic space, is
assumed to cross-bridge the MexB and OprM subunits (3, 11).
Recently, the crystal structure of the MexA subunit has been
resolved at the 2.40-Å resolution, revealing that the long ex-
tended protein structure consists of three main domains and
possibly one more disordered domain (12, 13). Based on the
crystal structure of MexA and simulated MexB and OprM
structures, the MexAB-OprM assembly model has been
proposed.
OprM is the outer membrane-associated lipoprotein that is
important in the final stage of antibiotic ejection across the
outer membrane (9, 14). In fact, permeability measurements by
means of a planar lipid bilayer and the liposome swelling assay
reported that OprM forms the channel that allows the diffusion
of small solutes (15, 16). The OprM protein lacking an amino-
terminal cysteine residue and consequently lacking all of the
fatty acids was predominantly recovered from the periplasmic
space but only slightly recovered from the outer membrane
fraction (14).
The TolC protein of Escherichia coli is a functional homo-
logue of OprM in that the presence of TolC is a prerequisite for
xenobiotic export by the AcrAB efflux pump, although the
protein showed only 21% amino acid identity with OprM (15).
The crystal structure of TolC had been resolved and the results
revealed that the protein consisted mainly of two domains: one
is the -barrel structure by which the protein anchored the
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outer membrane and another is a long -helical barrel that was
extended to the periplasmic space (17). Both ends of TolC had
a pore opening through which small solutes may diffuse. The
OprM protein differs from TolC: (i) the amino-terminal end of
the OprM was fatty acid modified (3, 14), whereas TolC has no
such modification, and (ii) OprM functions only for xenobiotic
discharge, while TolC is a multifunctional export protein en-
gaged in protein export and small xenobiotic extrusion (18). To
envisage the structure of this important transporter subunit
and advance the understanding of how the pump assembly
functions, we present the x-ray crystallographic structure of
OprM.
EXPERIMENTAL PROCEDURES
All the materials used and experimental procedures are given in the
supplemental materials section.
RESULTS AND DISCUSSION
Structure of the OpM Monomer—The mature form of OprM
containing 468 amino acid residues and NH2-terminal fatty
acids was crystallized in the presence of a surfactant mixture,
and diffraction data were obtained using synchrotron radia-
tion. The current model of OprM consisted of 456 residues
comprising 97.4% of the total amino acid residues. The OprM
monomer consisted of four -strands and eight -helices (Fig. 1,
A and B). -Strands were organized in a single -sheet cluster
by the antiparallel configuration. The -helix cluster mainly
consisted of two long -helices (67 and 69 residues) and four
short helices (23 and 36 residues) with the anti-parallel config-
uration. Tandem joining of two short -helices formed one set of
-helix similar in size and shape with a single long -helix. The
periplasmic end of the short -helix H8 was buried in the two
long -helical ends. Assembly of two long -helices and two sets
of short -helices per monomer were configured as if four long
-helices were in a bundle. The fatty acid-modified NH2-termi-
nal end was located at the interface of -helix and -sheet
clusters near Phe297 and Phe129.
The -sheet and -helix clusters were connected by four
short loops consisting of two to four amino acid residues. There
was a 110° turn at the junction of the -strand and -helix
clusters, thereby changing their orientation toward the same
direction and consequently forming a sickle shape. The aro-
matic amino acids, such as Phe85, Phe129, Phe296, Phe297, and
Phe335, at this region participated in the precise change of
strand direction at the junctions, H2-S1, S2-H3, H6-S3, and
S4-H7, respectively.
Overall Structure of the Trimer—Two OprM monomers were
contained in cystallographic asymmetric unit and each mono-
mers consisted trimeric structures, which were related crystal-
lographic 3-fold (Fig. 1A). The overall structure is reminiscent
of the TolC trimer of E. coli (17). Longitudinal and latitudinal
dimensions of the OprM trimer appeared to be 135 and 40–75
Å, respectively. The trimer consisted mainly of two domains: a
-barrel with a size of about 35 (height)  40–55 (width) Å and
an -barrel with a length of about 100 Å. Each -sheet was
tilted about 55° perpendicular to the plane of the membrane,
twisted rightwards, and extending to two-thirds the distance
along the -barrel forming the barrel wall and a central pore.
Near the top of the -barrel, there were three short loops; they
protruded toward the inside of the pore forming a constriction.
The pore diameter was calculated to be about 6–8 Å at the
constriction, which is much smaller than that of TolC (Fig. 2A).
The -barrel is likely inserted into the outer membrane matrix,
analogous to the consensus -barrel structure of most integral
outer membrane proteins of Gram-negative bacteria (19). The
surface of the -barrel is hydrophobic and both ends of the
-barrel are positively charged (data not shown), and these
electrostatic and hydrophobic features of the -barrel strongly
support the above hypothesis.
The -barrel was formed by a bundle of 6 long -helices and
12 short -helices. Right-hand twists of -helices toward the
proximal ends narrowed the barrel end and spontaneously
formed a bulge near the equator. Thus, the interior of the
trimer formed a huge and long cavity along the longitudinal
axis, with a volume of 25,000 Å3, which was probably filled
with solvents. The cavity was gradually constricted along the
proximal end and was totally closed at the tip (Fig. 2, A and B).
This structure seems plausible, since the ground state of OprM
should not allow access of xenobiotics to the interior of the cells.
Inlet and Outlet of the Cavity—The pore opening observed in
the -barrel with a diameter of about 6–8 Å, which is not large
enough to accommodate the passage of any antibiotics (Fig.
2A). The periplasmic end of the -barrel was tightly sealed,
possibly not allowing the passage of any molecules in the
ground state (Fig. 2, A and B).
A question to be answered is how the -barrel pore can be
dilated. The crystal structure showed two OprM molecules in
different environment (Fig. 3A). Although all the amino acid
residues in the -barrel of the A unit could be traced, a large
part of that of the B unit showed disordered structure (Fig. 3A).
The results suggest that the upper part of the -barrel is
FIG. 1. Stereoscopic view and sec-
ondary structure topology model of
OprM. A, stereoscopic view of the OprM
trimer ribbon model. One monomer unit
was distinguished from the other two
with a blue and green. B, secondary struc-
ture topology model of the OprM mono-
mer. The topology was constructed on the
basis of the x-ray crystallographic struc-
ture of the molecule A, and secondary
structure elements were defined by the
DSSP program (28). The arrows and box
represent the -sheet and -helix, respec-
tively. N and C represent amino and car-
boxyl termini.
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flexible. This assumption was supported by the fact that the
-barrel of one of the molecules in a crystal (molecule B in Fig.
3A) shows extremely high temperature factors (Fig. 3A). The
-barrel contained 18 residues of proline per trimer, which is
known to have a tendency to break the protein secondary
structure and 33 residues of glycine per trimer that confers
fragility on the protein structure (Fig. 3B).
An even greater problem would be the periplasmic end of the
-barrel through which antibiotics may be injected into the
OprM cavity. The -helices at the periplasmic end were twisted
causing closure of the cavity end. The gate was constructed by
stacking of hydrophilic, hydrophobic, and hydrophilic amino
acid networks (supplemental Fig. 1) that is flexible as shown by
the high temperature factors (Fig. 3). The hydrophobic gate
was formed by the triplet of Leu412 that may not allow the
passage of even a water molecule (Fig. 2B). Two hydrophilic
layers were constructed by Asp416–Arg419 and Asn410–Thr413
that sandwiched the hydrophobic layer (supplemental Fig. 1).
This tightly sealed -barrel end must be opened to allow the
entry of antibiotics.
Proposal for the Mechanism of Opening the Closed Periplas-
mic End—The proximal end of the OprM -barrel was tightly
sealed by the inward twisting of helices 7 and 8, while helices
3 and 4 were positioned outside and interacted with MexB (Fig.
1A). This inward twisting seems to be maintained by strong
intra- and intermolecular hydrogen bonding resulting in a turn
of H7 and H8 at Gly377 and Val440, respectively. If these turned
-helices could be linear, the periplasmic gate of the -barrel
could be opened. Hinges of this door are likely located near the
equator of helices 7 and 8. The -carbon of Arg376 and Gly377 of
helix 7 and Glu439 and Val440 of helix 8 are aligned linearly;
their 18° outward tilting at the hinges causes movement of the
occluding Leu412 -carbon 9.8 Å outward resulting in opening
of a pore with a diameter of 11 Å or more (supplemental Fig. 4,
movement of helices 7 and 8 of the cyan -helices to the ma-
genta -helices). The model cannot predict the force that pulls
out helices 7 and 8. Since OprM most likely interacts with
MexB at the tip of helices 3 and 4, helices 7 and 8 are free from
contact with MexB (see below). It is tempting to predict that
this task may take place with the MexA subunit rather than
MexB. A mechanism for the periplasmic pore dilation of the
TolC trimer has been proposed that modification of the salt
bridges at the tip of the periplasmic end enlarges the pore (20).
However, the proposal did not consider possible involvement of
the cognate subunit proteins such as AcrA and AcrB. The
model proposed for pore opening of OprM is not mutually
exclusive with that of TolC of E. coli. Further experimental
data are needed to verify these models.
Membrane Anchoring—The amino-terminal cysteine residue
of the OprM protein was fatty acid-modified. Removal of acyl
chains had little effect on the function of OprM, although the
majority of delipidated OprM had been recovered from the
periplasmic space (14). Based on this result, we hypothesized
that OprM might anchor the outer membrane solely via the
acyl chains (14). However, the crystal structure did not support
this conclusion and revealed that OprM anchors the outer
membrane by two modes: via the NH2-terminal fatty acids and
the transmembrane -barrel. The x-ray crystallography
FIG. 2. OprM cavity and the cavity ends. A, vertical views and horizontal slices of the OprM trimer. Three monomers are colored blue, red,
and green. The left figure shows a vertical view of the OprM trimer. The right figures exhibited horizontal slices of the OprM trimer at the -barrel,
equator, and the periplasmic end. Approximate pore diameters are shown. B, periplasmic end of the OprM trimer. Triplet Leu412 residues are
shown by the space-filling model (yellow). The remaining amino acid residues are shown by a stick model.
FIG. 3. Comparison of asymmetric units A and B of the OprM
monomer. A, the ribbon model was drawn with a temperature factor in
a gradient color. Note the disordered -sheets at the top of the B unit
and high temperature factors at the top and the bottom. B, localization
of glycine and proline molecules in the -barrel. The space-filling model
was given only to one OprM. Blue, glycine; red, proline.
FIG. 4. Stereoscopic view of the OprM-MexB junction. Side view
of the OprM-MexB junction in the trimeric form was shown. Arrays of
hydrophobic amino acids, Val198-Gly199-Val200 of OprM (red, magenta,
and yellow) and that of Ala736-Leu737-Gly738 of MexB (blue, cyan, and
white) were shown by the space-filling model.
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showed a poorly resolved density map beyond the amino-ter-
minal Cys1 residue suggesting that this might be the fatty acid
moiety (supplemental Fig. 2). The occurrence and structural
clarification of a membrane protein that has two modes of
membrane anchoring was a new finding to the best of our
knowledge, although such a possibility was suggested in the
outer membrane component of the capsular polysaccharide
transport machinery in E. coli (21).
It would be of interest to address the physiological relevance
of two modes of membrane anchoring. OprM has extremely
large and hydrophilic surface areas, an external surface and
internal cavity wall, which may need an additional membrane
anchoring device to ensure transmembrane anchoring of the
drug discharge duct (Fig. 2). This hypothesis was supported by
the fact that the delipidated OprM was largely located in the
periplasmic space (14) and by the structural fragility of the
-barrel (Fig. 3B). Alternatively, it is also possible that fatty
acids play a role in the proper sorting of OprM to the outer
membrane as documented in the E. coli Lol system (22). The
fact that OprM lacks a carboxyl-terminal outer membrane sort-
ing signal, i.e. Phe-X-Phe (COOH-terminal) (23), supports the
above notion. However, TolC has neither a COOH-terminal
outer membrane-sorting signal nor a NH2-terminal fatty acid
modification, yet the protein was properly sorted to the outer
membrane.
Interaction of OprM with Cognate Subunits MexA and
MexB—In vivo interaction of OprM with MexA and MexB has
been demonstrated by co-purification of non-tagged MexA and
MexB with his-tagged OprM (24) and by a chemical cross-
linking experiment (25). Recently proposed MexAB-OprM as-
sembly models showed that the coiled-coil domain of MexA
interacts with OprM and both - and -domains interact
with MexB (12, 13). In fact, domain swapping experiments
among P. aeruginosa membrane fusion protein revealed that
the coiled-coil domain reserves the outer membrane selective
determinant.1 In addition, a genetic experiment revealed that
function-restored secondary mutations that complement func-
tionally compromised TolC of E. coli were predominantly
mapped in the -domain of AcrA (26) suggesting that the
-domain of AcrA may interact with TolC. Adopting these
observations to explain the MexAB-OprM assembly, we revised
the assembly model as follows. The OprM -barrel provides at
least two MexA binding sites: one for the coiled-coil -helical
domain and one for the -domain.
The next question for consideration is how OprM interacts
with MexB. We constructed an OprM-MexB fitting model based
on the OprM crystal structure and the simulated MexB model.
The computer-aided manual search of close proximity and best
fitting of the periplasmic end of the OprM to the distal end of
the MexB funnel top found hydrophobic contact between these
two subunits (Fig. 4). An array of hydrophobic amino acid
residues of OprM, Val198-Gly199-Val200 (a loop between H3 and
H4), provides perfect contact with an array of Ala736-Leu737-
Gly738 of MexB (supplemental Fig. 3). Three hydrophobic con-
tact sites in the OprM-MexB trimer strengthen the subunit
interaction and contribute to the MexAB-OprM pump assem-
bly. This contact may be maintained in either the closed or
open state of the periplasmic end, because Val198-Gly199-Val200
is less likely to be involved in gate formation (supplemental
Fig. 4). Arrays of hydrophobic amino acids found in OprM and
MexB are also conserved in TolC and AcrB, respectively.
The MexA-MexB interaction is likely to occur at the disor-
dered domain of MexA and the funnel domain of MexB. This
assumption was supported by the earlier observation (25, 27).
The remaining question is whether or not the 25 amino-termi-
nal residues of MexA that are extended toward the outside of
the -domain can reach the inner membrane. This short
peptide consisted of a short -sheet and a random coil that is
most likely extended by a distance of about 50 Å toward the
inner membrane and is long enough to reach the inner mem-
brane. Fatty acids attached to this NH2-terminal end must be
inserted into the hydrophobic domain of the inner membrane.
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